Quick Takeaways
- TANG CAPITAL MANAGEMENT LLC filed SCHEDULE 13G/A for Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH).
- Disclosed ownership: 4.8%.
- Date of event: 30 Jun 2025.
Quoteable Key Fact
"TANG CAPITAL MANAGEMENT LLC disclosed 4.8% ownership in Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share (RVPH) on 30 Jun 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT, LLC | 4.8% | 3,399,975 | 0 | 3,399,975 | Kevin Tang | Manager | |
| KEVIN TANG | 4.8% | 3,399,975 | 0 | 3,399,975 | Kevin Tang | Self | |
| TANG CAPITAL PARTNERS, LP | 4.8% | 3,399,975 | 0 | 3,399,975 | Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0% | 0 | 0 | 0 | Kevin Tang | Manager, Tang Capital Management, LLC, General Partner | |
| TANG CAPITAL PARTNERS III, INC | 0% | 0 | 0 | 0 | Kevin Tang | Chief Executive Officer | |
| TANG CAPITAL PARTNERS IV, INC | 0% | 0 | 0 | 0 | Kevin Tang | Chief Executive Officer |